Journal Abbreviation: CANCER RES Journal ISSN: 0008-5472Year Impact Factor (IF) Total Articles Total Cites 2023 (2024 update) 12.5 253 122978 2022 11.2 - 141481 2021 13.312 - 161957 2020 12.701 453 159236 2019 9.727 536 135753 2018 8.378 555 130932 2017 9.130 632 139291 2016 9.122 648 ...
Journal ISSN: 1474-175X About Nature Reviews Cancer The ultimate aim of cancer research is to eliminate this common and devastating disease from the human population. To develop more effective prevention methods we need to understand what triggers carcinogenesis. To diagnose precancerous lesions and...
2024年6月20日,科睿唯安(Clarivate Analytics,原汤森路透知识产权与科技事业部)发布了一年一度的期刊引证报告(Journal Citation Reports)。AME旗下杂志Translational Lung Cancer Research(中文名为《肺癌转化研究》杂志,简称TLCR杂志,图2)获得最新影响因子(Impact Factor,简称IF):4分。 图1TLCR杂志的引证报告 图2TLCR...
1 Dec 2024 Journal of cancer research and therapeutics Research progress on the structural and anti-colorectal malignant tumor properties of Shikonin. 1 Dec 2024 Journal of cancer research and therapeutics Factors retarding enhanced recovery from thermal ablation of liver tumors: A single-center prospect...
Journal Impact Factor: 3.5 5-year Journal Impact Factor: 4.3 Source Normalized Impact per Paper (SNIP): 1.416 SCImago Journal Rank (SJR): 1.227 Speed 2024 Submission to first editorial decision (median days): 11 Submission to acceptance (median days): 157 ...
Breast Cancer Research is the highest ranking breast cancer-specific title in the top quartile of oncology journals worldwide. Primarily publishing original ...
Our journal websites will be undergoing scheduled maintenance this weekend. During this period, access to our journals may be disrupted. We apologise in advance for any inconvenience. >
Citation Impact 2023 Journal Impact Factor: 3.8 5-year Journal Impact Factor: 4.2 Source Normalized Impact per Paper (SNIP): 0.957 SCImago Journal Rank (SJR): 0.968 Speed 2024 Submission to first editorial decision (median days): 8 Submission to acceptance (median days): 124 ...
Cancer Immunology, Immunotherapyis providing a timely and open access publication of original discovery and developments in basic and translational research in the field of cancer immunology and immunotherapy. Editor-in-Chief Haidong Dong Journal Impact Factor ...
About the journal An international journal providing a forum for original and pertinent contributions in cancer research Cancer Lettersis an international journal that considers full-length articles and Mini Reviews in the broad area of basic andtranslational oncology. Additionally, Special Issues highlight...